Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Short-Term Debt issuances

Growth Metrics

Others

Balance Labs (BLNC) Capital Expenditures (2016 - 2018)

Balance Labs filings provide 1 years of Capital Expenditures readings, the most recent being $1561.0 for Q1 2018.

On a quarterly basis, Capital Expenditures changed N/A to $1561.0 in Q1 2018 year-over-year; TTM through Dec 2021 was $1561.0, a N/A change, with the full-year FY2021 number at $9500.0, changed N/A from a year prior.
Capital Expenditures hit $1561.0 in Q1 2018 for Balance Labs.
In the past five years, Capital Expenditures ranged from a high of $1561.0 in Q1 2018 to a low of $1561.0 in Q1 2018.